A cluster randomized non-inferiority field trial on the immunogenicity and safety of tetanus toxoid vaccine kept in controlled temperature chain compared to cold chain

Hdl Handle:
http://hdl.handle.net/10144/336354
Title:
A cluster randomized non-inferiority field trial on the immunogenicity and safety of tetanus toxoid vaccine kept in controlled temperature chain compared to cold chain
Authors:
Juan-Giner, A; Domicent, C; Langendorf, C; Roper, M H; Baoundoh, P; Fermon, F; Gakima, P; Zipursky, S; Tamadji, M; Grais, R
Journal:
Vaccine
Abstract:
In resource-poor settings, cold chain requirements present barriers for vaccine delivery. We evaluated the immunogenicity and safety of tetanus toxoid (TT) vaccine in "Controlled Temperature Chain" (CTC; up to 40°C for <30 days before administration), compared to standard cold chain (SCC; 2-8°C). Prior to the study, stability parameters of TT-CTC were shown to meet international requirements.
Issue Date:
23-Sep-2014
URI:
http://hdl.handle.net/10144/336354
DOI:
10.1016/j.vaccine.2014.09.027
PubMed ID:
25261378
Additional Links:
http://www.sciencedirect.com/science/journal/0264410X
Language:
en
ISSN:
1873-2518
Appears in Collections:
Vaccination

Full metadata record

DC FieldValue Language
dc.contributor.authorJuan-Giner, Aen_GB
dc.contributor.authorDomicent, Cen_GB
dc.contributor.authorLangendorf, Cen_GB
dc.contributor.authorRoper, M Hen_GB
dc.contributor.authorBaoundoh, Pen_GB
dc.contributor.authorFermon, Fen_GB
dc.contributor.authorGakima, Pen_GB
dc.contributor.authorZipursky, Sen_GB
dc.contributor.authorTamadji, Men_GB
dc.contributor.authorGrais, Ren_GB
dc.date.accessioned2014-11-30T15:27:07Z-
dc.date.available2014-11-30T15:27:07Z-
dc.date.issued2014-09-23-
dc.identifier.citationA cluster randomized non-inferiority field trial on the immunogenicity and safety of tetanus toxoid vaccine kept in controlled temperature chain compared to cold chain. 2014: Vaccineen_GB
dc.identifier.issn1873-2518-
dc.identifier.pmid25261378-
dc.identifier.doi10.1016/j.vaccine.2014.09.027-
dc.identifier.urihttp://hdl.handle.net/10144/336354-
dc.description.abstractIn resource-poor settings, cold chain requirements present barriers for vaccine delivery. We evaluated the immunogenicity and safety of tetanus toxoid (TT) vaccine in "Controlled Temperature Chain" (CTC; up to 40°C for <30 days before administration), compared to standard cold chain (SCC; 2-8°C). Prior to the study, stability parameters of TT-CTC were shown to meet international requirements.en_GB
dc.languageENG-
dc.language.isoenen
dc.relation.urlhttp://www.sciencedirect.com/science/journal/0264410Xen_GB
dc.rightsPublished by Elsevier Archived on this site with kind permission by Elsevier's Open Access policyen_GB
dc.titleA cluster randomized non-inferiority field trial on the immunogenicity and safety of tetanus toxoid vaccine kept in controlled temperature chain compared to cold chainen
dc.identifier.journalVaccineen_GB

Related articles on PubMed

All Items in MSF are protected by copyright, with all rights reserved, unless otherwise indicated.